Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
endingPage |
3514 |
issn |
1381-6128 |
issueIdentifier |
32 |
pageRange |
3506-3514 |
publicationName |
Current Pharmaceutical Design |
startingPage |
3506 |
bibliographicCitation |
Dolezal M, Kesetovic D, Zitko J. Antimycobacterial evaluation of pyrazinoic acid reversible derivatives. Curr Pharm Des. 2011;17(32):3506–14. doi: 10.2174/138161211798194477. PMID: 22074423. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53d454761b405b6dd0090ccdaa07db3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fba0470bfa5b8ac977cec60ff6ec364 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69e9c491ebc9cfab6817a1c830916774 |
date |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.2174/138161211798194477 https://pubmed.ncbi.nlm.nih.gov/22074423 |
isPartOf |
https://portal.issn.org/resource/ISSN/1381-6128 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21197 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives |
discusses |
http://id.nlm.nih.gov/mesh/M0046746 http://id.nlm.nih.gov/mesh/M0018224 http://id.nlm.nih.gov/mesh/M0017642 http://id.nlm.nih.gov/mesh/M0448397 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9261 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1047 |